Related Experiment Video
Updated: Jan 22, 2026

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
Published on: December 18, 2020
The value of networks in driving phase I trials: the Peter MacCallum Cancer Centre experience
Jayesh Desai1, Christina Guo2, Ben Tran2
1Early Drug Development Program and Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Jayesh.Desai@petermac.org.
Abstract:
The Peter MacCallum Cancer Centre is strongly focused on the conduct of translational research in driving towards better outcomes for patients. Central to this is our clinical trials program, with a strategic focus on early phase trials. Our efforts in developing a world-class program focused on early phase trials have been critically dependent on the creation and collaboration with key networks: local, regional and global. In this paper, we will articulate how the early drug development landscape has evolved in Australia, and how and why collaboration has been such a critical enabler for us in driving success.
Insights
Peter MacCallum Cancer Centre enhances patient outcomes through translational research and early phase clinical trials. Collaboration with local, regional, and global networks is crucial for success in Australia's evolving drug development landscape.
Area of Science:
- Oncology
- Translational Research
- Clinical Trials
Background:
- Peter MacCallum Cancer Centre prioritizes translational research for improved patient outcomes.
- A strong clinical trials program, with a focus on early phase trials, is central to this mission.
- Developing a world-class early phase trials program relies on strategic network creation and collaboration.
Purpose of the Study:
- To articulate the evolution of the early drug development landscape in Australia.
- To explain the critical role of collaboration in the success of early phase trials.
- To highlight the strategies employed by Peter MacCallum Cancer Centre in fostering collaborative networks.
Main Methods:
- Review of the Australian early drug development landscape.
- Analysis of the impact of network collaboration on clinical trial success.
- Case study of Peter MacCallum Cancer Centre's approach to building research networks.
Main Results:
- The early drug development sector in Australia has undergone significant evolution.
- Collaboration is a key enabler for the success of early phase cancer trials.
- Strategic network development is essential for a robust clinical trials program.
Conclusions:
- Translational research and early phase trials are vital for advancing cancer care.
- Effective collaboration across local, regional, and global networks is paramount.
- Peter MacCallum Cancer Centre's success is underpinned by its commitment to collaborative research initiatives.
More Related Videos
06:28A Networked Desktop Virtual Reality Setup for Decision Science and Navigation Experiments with Multiple Participants
Published on: August 26, 2018
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Trial and Error and Algorithm
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...